pharmaphorum June 20, 2024
The non-profit International Society for Infectious Diseases (ISID) has published a set of six priorities focusing on the challenges faced by low- and middle-income countries (LMICs) ahead of its congress later this year.
It is the first time the ISID has set out such a list, which reflects the challenges being faced by LMICS with “limited healthcare infrastructure, fewer economic resources, and a disproportionate infectious disease burden,” and emphasises the strong interdependence of human health, domestic and wild animals, and the wider environment.
As might be expected, top of the list is the rising tide of antimicrobial resistance (AMR) – sometimes referred to as the ‘silent pandemic’ – and the prospect that increasing numbers of infections will become untreatable as...